Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,609 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,034
Recruiting: 591
Ph III recruiting: 61
Growth YoY: +8.6%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (799)

clinicaltrialsPublishedShowing 201–250 of 415 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04953897	Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment	recruiting	Phase 1	18	Taiho Oncology, Inc.INDUSTRY	8	May 28, 2026	clinicaltrials
NCT04953910	Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment	recruiting	Phase 1	27	Taiho Oncology, Inc.INDUSTRY	8	May 28, 2026	clinicaltrials